• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Passage Bio, Inc. - Common Stock (NQ:PASG)

3.600 UNCHANGED
Delayed Quote Updated: 3:56 PM EDT, Oct 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.600
Bid (Size) 3.400 (400)
Ask (Size) 4.250 (500)
Prev. Close 3.600
Today's Range 3.600 - 3.600
52wk Range 3.290 - 20.00
Shares Outstanding 61,767,286
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
PASG Stock Alert: Halper Sadeh LLC is Investigating Whether Passage Bio, Inc. is Obtaining a Fair Price for its Shareholders
Today 3:04 EDT
From Halper Sadeh LLC
Via Business Wire
Keep an eye on the top gainers and losers in Thursday's session. ↗
June 25, 2026
Via Chartmill

Performance

52-Week Range 82.0% below 52-week high
3.600
3.2952W Low 20.0052W High
1 Week 8.4% below 1-week high
3.371W Low 3.931W High

Passage Bio, Inc. - Common Stock (PASG) traded between $3.29 and $20.00 over the past 52 weeks and last traded at $3.60, 82.0% below its 52-week high. Over the past week it ranged between $3.37 and $3.93.

Past 12 Months
-1.6%
-25.5%
-26.7%
-41.7%
-69.2%
-57.8%
1W -$0.06
1M -$1.23
3M -$1.31
6M -$2.58
YTD -$8.09
1Y -$4.94

PASG was -57.8% over the past year, -41.7% over six months, -69.2% year to date, -1.6% in the last week.

12 Months vs Market
PASG
-57.8%
DIA
+12.3%
SPY
+14.6%
QQQ
+17.3%
IWM
+11.1%

Over the past 12 months PASG returned -57.8% versus DIA (Dow) +12.3%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +17.3% and IWM (Russell 2000) +11.1%.

Volume & Liquidity
1W
11.4K
1M
22.3K
3M
21.0K
6M
58.0K
YTD
62.9K
1Y
59.3K

PASG's 3-month average daily volume is 21.0K.

More News

Read More
Which stocks are moving before the opening bell on Thursday? ↗
June 25, 2026
Via Chartmill
News headline image
Passage Bio and Remix Therapeutics Announce Merger Agreement
June 24, 2026
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates
April 20, 2026
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights
March 03, 2026
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio to Participate in Upcoming Investor Conferences
February 19, 2026
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights
November 10, 2025
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference
November 05, 2025
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference
October 14, 2025
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference
August 28, 2025
From Passage Bio
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
August 12, 2025
Via Benzinga
News headline image
Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights
August 12, 2025
From Passage Bio
Via GlobeNewswire
News headline image
Friday's session: top gainers and losers ↗
July 25, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
July 25, 2025
Via Benzinga
News headline image
Gapping stocks in Friday's session ↗
July 25, 2025
Via Chartmill
News headline image
What's going on in today's after hours session ↗
July 11, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
July 10, 2025
Via Benzinga
News headline image
Passage Bio Announces 1-for-20 Reverse Stock Split
July 10, 2025
From Passage Bio
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
June 26, 2025
Via Benzinga
News headline image
Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update
June 23, 2025
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights
May 13, 2025
From Passage Bio
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
May 12, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
April 30, 2025
Via Benzinga
News headline image
The market is filled with gapping stocks in Thursday's session. ↗
April 03, 2025
Via Chartmill

Frequently Asked Questions

Is Passage Bio, Inc. - Common Stock publicly traded?
Yes, Passage Bio, Inc. - Common Stock is publicly traded.
What exchange does Passage Bio, Inc. - Common Stock trade on?
Passage Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Passage Bio, Inc. - Common Stock?
The ticker symbol for Passage Bio, Inc. - Common Stock is PASG on the Nasdaq Stock Market
What is the current price of Passage Bio, Inc. - Common Stock?
The current price of Passage Bio, Inc. - Common Stock is 3.600
When was Passage Bio, Inc. - Common Stock last traded?
The last trade of Passage Bio, Inc. - Common Stock was at 10/20/26 03:56 PM ET
What is the market capitalization of Passage Bio, Inc. - Common Stock?
The market capitalization of Passage Bio, Inc. - Common Stock is 222.36M
How many shares of Passage Bio, Inc. - Common Stock are outstanding?
Passage Bio, Inc. - Common Stock has 222M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap